4.4 out of 5 stars
(919 Ratings)
Qualio is a unified quality and compliance platform that helps growing life sciences companies scale faster while staying continuously audit- and inspection-ready. Medical device, digital health, biotech, and pharma teams use Qualio to replace manual processes and disconnected tools with a single source of truth for quality, regulatory readiness, and risk.
With a modern eQMS at the foundation and Compliance Intelligence layered on top, Qualio moves teams beyond point-in-time audits. Automated gap analysis, cross-standard evidence mapping, and real-time readiness dashboards provide confidence that the organization is prepared today—not just when auditors arrive.
Qualio centralizes document control, training, CAPA, change management, supplier quality, and design controls, linking them directly to regulatory requirements and product lifecycle data. Executive-ready views show compliance health by standard, region, and product, turning regulatory readiness into a measurable business capability instead of a black box.
Compliance Intelligence continuously monitors for risk, highlights gaps early, and prioritizes remediation so teams focus effort where it matters most. Pre-validated regulatory frameworks are maintained as requirements evolve, reducing reliance on consultants and avoiding duplicate work as companies expand.
The result is faster market entry, lower compliance cost, reduced risk of findings or recalls, and confident, risk-managed growth.
Learn more about Qualio
4.8 out of 5 stars
(2 Ratings)
Polonious serves as an investigation management workflow solution that adheres to ISO27001 standards, built upon three foundational principles:
1 - Security
2 - Process orientation
3 - Adaptability and customization
This framework empowers users to design workflows that not only safeguard data and evidence in a secure, ISO27001 certified manner but also streamline compliance with regulatory obligations with minimal hassle, thanks to workflows that are inherently compliant. Furthermore, the platform eliminates the need for costly and time-intensive coding alterations, allowing users to make modifications independently through an intuitive graphical user interface (GUI).
Additionally, Polonious offers the capability to generate comprehensive reports on case outcomes, timelines, and financial metrics, which can be analyzed by case types, investigators, and investigation statuses. This functionality not only demonstrates value to higher management but also aids in pinpointing inefficiencies, paving the way for enhanced operational productivity. By leveraging these insights, organizations can continually refine their investigation processes to achieve better results.
Learn more about Polonious
CoVigilAI
CoVigilAI represents a state-of-the-art innovation in the realm of medical literature monitoring, harnessing the power of artificial intelligence and advanced data analytics to proactively detect and manage adverse drug reactions, ensuring patient safety and compliance with regulatory requirements in real-time. This platform facilitates the efficient tracking of scientific and medical literature by retrieving data from prominent global databases such as PubMed and Embase, and it offers customizable search options that improve the pharmacovigilance literature review process. Furthermore, it conducts thorough evaluations of scientific articles and publications from various regional journals, guaranteeing an extensive oversight of both global and localized literature. With the implementation of sophisticated algorithms, the system categorizes Individual Case Safety Reports (ICSRs) into three distinct classifications: valid, potential, and invalid cases, while its automated key entity recognition feature proficiently pinpoints critical components such as patients, medications, adverse reactions, and pertinent medical events. This comprehensive strategy not only streamlines the monitoring procedure but also considerably boosts the precision and efficiency of drug safety evaluations, contributing to a safer healthcare environment. Ultimately, CoVigilAI serves as an indispensable tool for enhancing drug safety and fostering informed decision-making in the medical field.
Learn more about CoVigilAI
Cloudbyz Safety and Pharmacovigilance (PV)
The Cloudbyz Safety & Pharmacovigilance Solution is a cloud-based platform tailored to enhance drug safety and pharmacovigilance for companies in the pharmaceutical and life sciences sectors. This innovative solution automates the entire workflow of data collection, processing, analysis, and reporting in adherence to global regulatory standards.
Cloudbyz offers comprehensive management of the pharmacovigilance lifecycle, encompassing adverse event processing, case management, regulatory reporting, signal detection, and risk management. By utilizing Cloudbyz, organizations can streamline their pharmacovigilance operations, expedite case processing, and boost the precision of their safety data, all while mitigating risks and ensuring compliance with regulations. Additionally, the advantages of our solution include:
1. Enhanced efficiency through automation
2. Improved accuracy of data
3. Immediate visibility into processes
4. Better collaboration among teams
5. Strengthened adherence to regulatory requirements
Furthermore, adopting this solution empowers organizations to focus on innovation and patient safety, ultimately leading to improved outcomes in drug monitoring.
Learn more about Cloudbyz Safety and Pharmacovigilance (PV)